FGF21, Dietary Intake Interaction Impacts Adiposity

Share this content:
<i>FGF21</i>, Dietary Intake Interaction Impacts Adiposity
FGF21, Dietary Intake Interaction Impacts Adiposity

WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Fibroblast growth factor 21 (FGF21) genotypes may interact with dietary macronutrient intake to affect central adiposity and body fat composition, according to a study published online Aug. 31 in Diabetes Care.

Yoriko Heianza, from Tulane University in New Orleans, and colleagues genotyped FGF21 rs838147 in 715 overweight or obese individuals who were assigned to one of four diets with varied macronutrient contents.

The researchers observed a significant interaction between FGF21 genotype and carbohydrate/fat intake on two-year changes in waist circumference (WC) (P = 0.049), as well as percentage of fat mass and trunk fat (P = 0.001 and 0.003, respectively). Carrying the carbohydrate intake-decreasing C allele of rs838147 was marginally associated with less reduction in WC in response to the low-carbohydrate/high-fat diet (P = 0.08), and was significantly associated with less reduction of total fat mass and trunk fat (P = 0.01 and 0.02, respectively). Among the high-carbohydrate/low-fat diet group, opposite genetic associations with these outcomes were observed; carrying the C allele correlated with a greater reduction in WC, total body fat mass, and trunk fat.

"A low-calorie, high-carbohydrate/low-fat diet was beneficial for overweight or obese individuals carrying the carbohydrate intake-decreasing allele of the FGF21 variant to improve body composition and abdominal obesity," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »